Menu Search
Equities

Biocartis Group NV

0R72:LSE

Biocartis Group NV

Actions
  • Price (EUR)0.299
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-48.63%
  • Beta--
Data delayed at least 20 minutes, as of Sep 25 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

  • Revenue in EUR (TTM)60.61m
  • Net income in EUR-67.87m
  • Incorporated2014
  • Employees526.00
  • Location
    Biocartis Group NVGeneraal de Wittelaan 11BMALINES (MECHELEN) 2800BelgiumBEL
  • Phone+32 15632600
  • Websitehttps://biocartis.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.